TRC-00489 | Infliximab (Remicade®) (Human) ELISA Kit | 96 Well
Product Overview
A sandwich ELISA kit for the quantitative measurement of Infliximab (Remicade®) in Human serum and plasma.
Infliximab (Remicade®) is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFα) in the body by binding to it and preventing it from signaling the receptors for TNFα on the surface of various cell types. TNFα is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. 96Trace’s BioSimTM Infliximab ELISA kit has been developed for specific quantification of Infliximab concentration in human serum or plasma with high sensitivity and reproducibility.
Assay Information
| Assay Format | Sandwich ELISA |
| Species Reactivity | Human |
| Sample Type | Human serum and plasma |
| Detection Method | Absorbance (450 nm) |
| Detection Wavelength | 450 nm |
| Kit Size | 96 Well |
Performance Data
| Detection Range | 0.1 - 3 μg/ml |
| Sensitivity | 30 ng/ml |
Applications
This ELISA kit is used for quantitative measurement of Infliximab in human serum and plasma
Features & Benefits
- Designed for quantitative measurement of Infliximab (Remicade®).
- Assay format: Sandwich ELISA.
- Sample type: Human serum and plasma.
- Detection method: Absorbance (450 nm).
- Detection Range: 0.1 - 3 μg/ml
- Sensitivity: 30 ng/ml
- Kit size: 96 Well.
Storage & Shipping
| Storage | +4°C |
| Shipping | Gel Pack |
| Shelf Life | 12 Months |
Product Details
| Catalog Number | TRC-00489 |
| Analyte / Target | Infliximab (Remicade®) |